Latest
Recommended
Published: Thu, May 04, 2017
Economy | By Melissa Porter

Aetna Inc Boosts EPS Outlook Despite Negative Q1 Revenue Growth

Aetna Inc Boosts EPS Outlook Despite Negative Q1 Revenue Growth

Finally, Oppenheimer Holdings Inc. restated an outperform rating on shares of Aetna in a report on Friday, March 31st. Alpha One, a division of Accern, identifies negative and positive press coverage by reviewing more than 20 million news and blog sources in real time. They issued a "neutral" rating and a $136.00 price objective for the company.

Today, Cantor Fitzgerald reiterated its Overweight rating on Aetna (NYSE:AET) with a price target of $150.00. Aetna Inc. (NYSE:AET) shares have been recently spotted 0.78% away from the 52-week high, and 31.52% away from the 52-week low mark. Buy rating has been given by 1 analysts to the company stock whereas no analyst given UNDERPERFORM rating to stock and 11 analysts given HOLD rating. Sell-side analysts have also provided a consensus recommendation of 2.40 on company shares. The correct version of this article can be viewed at https://www.themarketsdaily.com/2017/05/03/aetna-inc-aet-shares-sold-by-washington-trust-bank-updated.html. The firm has a market cap of $48.95 billion, a price-to-earnings ratio of 21.71 and a beta of 0.61.

Stock is now moving with a positive distance from the 200 day simple moving average of approximately 14.57%, and has a solid year to date (YTD) performance of 12.68% which means the stock is constantly adding to its value from the previous fiscal year end price. That was mainly due to the $947 million it collected from the breakup fee associated with Aetna's failed bid to acquire Humana, the insurer said, plus higher year-over-year earnings for its retail segment. Earnings, adjusted for one-time gains and costs, were $2.71 per share.

The performance week for Aetna Inc.is at 3.15% while the performance month is at 8.20%. Seven analysts surveyed by Zacks expected $15.48 billion. The firm had revenue of $15.17 billion for the quarter, compared to analyst estimates of $15.39 billion.

Aetna expects full-year earnings in the range of $8.80 to $9 per share. Investors of record on Thursday, April 13th were paid a $0.50 dividend. The dividend yield stands at 1.46% while the payout ratio is 15.50%. Wells Fargo & Company MN raised its position in shares of Aetna by 1.2% in the third quarter.

On 9/30/2016 Aetna announced a quarterly dividend of $0.25 0.87% with an ex dividend date of 10/11/2016 which will be payable on 10/28/2016.

The current operating margin for Aetna Inc.is at 7.30%.

In related news, VP Francis S. Soistman, Jr. sold 6,607 shares of Aetna stock in a transaction that occurred on Wednesday, March 8th. Perhaps, that suggests something about why 0.49% of the outstanding share supply is held by institutional investors. Following the transaction, the vice president now directly owns 23,454 shares in the company, valued at $3,095,458.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In a transaction dated February 22, 2017, the shares were put up for sale at an average price of $128.87, raking in a sum of $1,021,939.

Earnings per share (EPS) breaks down the profitability of the company on a single share basis, and for Aetna Inc. the EPS stands at 1.63 for the previous quarter, while the analysts predicted the EPS of the stock to be 1.44, suggesting the stock exceeded the analysts' expectations. The disclosure for this sale can be found here.

The share price of Aetna Inc. The stock has climbed about 10 percent since the start of the year. Following the transaction, the insider now directly owns 44,880 shares of the company's stock, valued at $5,805,228. For the last period, the company reported quarter over quarter EPS growth of -56.90% and quarter over quarter sales growth of 4.50%.

In 2018, Aetna will cut that figure to three.

Like this: